SCHEMBL27615951

SCHEMBL27615951

CC(C)N(C)c1cc(NC(=O)O)c([N+](=O)[O-])cc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
AR P10275 4/20 0.44
CYP3A4 P08684 2/20 0.44
MAPK1 P28482 2/20 0.44
CES2 O00748 1/20 0.44
ABCB11 O95342 1/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
GLA P06280 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CHRM1 P11229 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
TBXA2R P21731 1/20 0.44
AADAC P22760 1/20 0.44
CYP2C19 P33261 1/20 0.44
ADRA1A P35348 1/20 0.44
HTT P42858 1/20 0.44
HTR6 P50406 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6608184 0.88 MAPT (0.42) ALDH1A1ARCYP3A4MAPK1CES2
SCHEMBL5557016 0.86 AR (0.41) ALDH1A1ARCYP3A4MAPK1CES2
SCHEMBL27615830 0.85 ALDH1A1 (0.41) ALDH1A1ARCYP3A4MAPK1CES2
SCHEMBL6608014 0.82 MAPT (0.39) ALDH1A1ARCYP3A4MAPK1CES2
SCHEMBL27615834 0.81 HCAR3 (0.39) ALDH1A1CYP3A4LMNACYP1A2CYP2C9
SCHEMBL27615871 0.80 IDH2 (0.36) ALDH1A1ARHTTRAB9AIDH2
SCHEMBL17336846 0.79 MAPT (0.46) ALDH1A1ARCYP3A4MAPK1CES2
SCHEMBL22636966 0.77 AR (0.42) ALDH1A1ARCYP3A4MAPK1CES2
SCHEMBL27615854 0.77 MAPT (0.46) ALDH1A1ARCYP3A4MAPK1CES2
SCHEMBL27597138 0.76 MAPT (0.44) ALDH1A1ARCYP3A4MAPK1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497333-C Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2009-06-10 CN disclosed
CN-1633430-A Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2005-06-29 CN disclosed